BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 21513938)

  • 1. Risk factors and incidence of ischemic stroke in Taiwanese with nonvalvular atrial fibrillation-- a nation wide database analysis.
    Lin LY; Lee CH; Yu CC; Tsai CT; Lai LP; Hwang JJ; Chen PC; Lin JL
    Atherosclerosis; 2011 Jul; 217(1):292-5. PubMed ID: 21513938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal impairment and ischemic stroke risk assessment in patients with atrial fibrillation: the Loire Valley Atrial Fibrillation Project.
    Banerjee A; Fauchier L; Vourc'h P; Andres CR; Taillandier S; Halimi JM; Lip GY
    J Am Coll Cardiol; 2013 May; 61(20):2079-87. PubMed ID: 23524209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-platelet or anti-coagulant agent for the prevention of ischemic stroke in patients with end-stage renal disease and atrial fibrillation--a nation-wide database analyses.
    Chen JJ; Lin LY; Yang YH; Hwang JJ; Chen PC; Lin JL
    Int J Cardiol; 2014 Dec; 177(3):1008-11. PubMed ID: 25449515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased risk of first-ever stroke in younger patients with atrial fibrillation not recommended for antithrombotic therapy by current guidelines: a population-based study in an East Asian cohort of 22 million people.
    Chang KC; Wang YC; Ko PY; Wu HP; Chen YW; Muo CH; Sung FC; Li TC; Hsu CY
    Mayo Clin Proc; 2014 Nov; 89(11):1487-97. PubMed ID: 25444485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the CHADS2 and CHA2DS2-VASc scores in post-myocardial infarction patients: Risk of new occurrence of atrial fibrillation and ischemic stroke.
    Lau KK; Chan PH; Yiu KH; Chan YH; Liu S; Chan KH; Yeung CY; Li SW; Tse HF; Siu CW
    Cardiol J; 2014; 21(5):474-83. PubMed ID: 24846512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
    Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
    J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant underuse of warfarin in patients with nonvalvular atrial fibrillation: results from the China national stroke registry.
    Wang C; Yang Z; Wang C; Wang Y; Zhao X; Liu L; Wang DZ; Li H; Wang Y
    J Stroke Cerebrovasc Dis; 2014; 23(5):1157-63. PubMed ID: 24291013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
    Piccini JP; Stevens SR; Chang Y; Singer DE; Lokhnygina Y; Go AS; Patel MR; Mahaffey KW; Halperin JL; Breithardt G; Hankey GJ; Hacke W; Becker RC; Nessel CC; Fox KA; Califf RM;
    Circulation; 2013 Jan; 127(2):224-32. PubMed ID: 23212720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
    Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliable identification of "truly low" thromboembolic risk in patients initially diagnosed with "lone" atrial fibrillation: the Belgrade atrial fibrillation study.
    Potpara TS; Polovina MM; Licina MM; Marinkovic JM; Prostran MS; Lip GY
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):319-26. PubMed ID: 22319004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
    Friberg L; Rosenqvist M; Lip GY
    Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antiplatelet therapy for stroke prevention in atrial fibrillation patients in the clinical practice of a single district hospital in Poland.
    Bednarski J; Cieszewska E; Strzelecki A; Filipiak KJ
    Kardiol Pol; 2013; 71(12):1260-5. PubMed ID: 23990227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of outcomes with aspirin or apixaban in relation to CHADS(2) and CHA(2)DS(2)-VASc scores in patients with atrial fibrillation: a secondary analysis of the AVERROES study.
    Lip GY; Connolly S; Yusuf S; Shestakovska O; Flaker G; Hart R; Lanas F; Xavier D; Eikelboom J;
    Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):31-8. PubMed ID: 23390125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation: A Nationwide Cohort Study From Taiwan.
    Chao TF; Wang KL; Liu CJ; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Chiang CE; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Sep; 66(12):1339-47. PubMed ID: 26383720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    Son MK; Lim NK; Kim HW; Park HY
    PLoS One; 2017; 12(6):e0179687. PubMed ID: 28636620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age Threshold for Ischemic Stroke Risk in Atrial Fibrillation.
    Kim TH; Yang PS; Yu HT; Jang E; Uhm JS; Kim JY; Pak HN; Lee MH; Joung B; Lip GYH
    Stroke; 2018 Aug; 49(8):1872-1879. PubMed ID: 30012820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble CD40 ligand predicts ischemic stroke and myocardial infarction in patients with nonvalvular atrial fibrillation.
    Ferro D; Loffredo L; Polimeni L; Fimognari F; Villari P; Pignatelli P; Fuster V; Violi F
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2763-8. PubMed ID: 17901373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Documentation of atrial fibrillation prior to first-ever ischemic stroke.
    Baturova MA; Lindgren A; Shubik YV; Olsson SB; Platonov PG
    Acta Neurol Scand; 2014 Jun; 129(6):412-9. PubMed ID: 24299072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for poor outcome and mortality at 3 months after the ischemic stroke in patients with atrial fibrillation.
    Li S; Zhao X; Wang C; Liu L; Liu G; Wang Y; Wang C; Jing J; Wang YJ
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e419-25. PubMed ID: 23721617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.